Repositioning Candidate Details

Candidate ID: R0401
Source ID: DB01094
Source Type: experimental
Compound Type: small molecule
Compound Name: Hesperetin
Synonyms: (−)-(S)-hesperetin; (−)-hesperetin; (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one; 3',5,7-Trihydroxy-4'-methoxyflavanone; Hesperitin
Molecular Formula: C16H14O6
SMILES: COC1=C(O)C=C(C=C1)[C@@H]1CC(=O)C2=C(O)C=C(O)C=C2O1
Structure:
DrugBank Description: Hesperetin belongs to the flavanone class of flavonoids. Hesperetin, in the form of its glycoside , is the predominant flavonoid in lemons and oranges.
CAS Number: 520-33-2
Molecular Weight: 302.2788
DrugBank Indication: For lowering cholesterol and, possibly, otherwise favorably affecting lipids. <i>In vitro</i> research also suggests the possibility that hesperetin might have some anticancer effects and that it might have some anti-aromatase activity, as well as activity again.
DrugBank Pharmacology: Hesperetin is a cholesterol lowering flavanoid found in a number of citrus juices. It appears to reduce cholesteryl ester mass and inhibit apoB secretion by up to 80%. Hesperetin may have antioxidant, anti-inflammatory, anti-allergic, hypolipidemic, vasoprotective and anticarcinogenic actions.
DrugBank MoA: Hesperetin reduces or inhibits the activity of acyl-coenzyme A:cholesterol acyltransferase genes (ACAT<sub>1</sub> and ACAT<sub>2</sub>) and it reduces microsomal triglyceride transfer protein (MTP) activity. Hesperetin also seems to upregulate the LDL receptor. This leads to the reduced assembly and secretion of apoB-containing lipoproteins and enhanced reuptake of those lipoproteins, thereby lowering cholesterol levels.
Targets: Sterol O-acyltransferase 1 inhibitor; Sterol O-acyltransferase 2 inhibitor; Microsomal triglyceride transfer protein large subunit antagonist; Sex hormone-binding globulin
Inclusion Criteria: Therapeutic strategy associated